EUTM file information

001042951

AdApt


January 13, 1999

Trademark Summary

The trademark AdApt was filed by Janssen Vaccines & Prevention B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on September 19, 1999, and received one opposition filed on December 19, 1999 by null on Likelihood of confusion. the opponent was represented by HGF LIMITED and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 19, 1999

The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).

The renewal of the trademark was recorded by the office on November 14, 2009.

of the trademark registration was recorded on November 14, 2009. Change of name and address of the trademark registration was recorded on November 14, 2001. Change of name and professional address of the trademark registration was recorded on August 5, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 2, 2007. Appointment and Replacement of representative of the trademark registration was recorded on February 3, 2008.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Genetically modified material for the preparation of pharmaceutical products and for research and diagnostic purposes
    2. Pharmaceutical products especially for gentherapy
    3. Cells and cell lines containing such genetically modified material
    4. Proteins, polypeptides
    5. Biochemicals.
  • The mark was filed in class 40 with Treatment of materials for the preparation of pharmaceutical products or genetically modified material.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific research
    2. Services in the medical and biochemical field, especially examination and testing of genes
    3. Development, examination and testing of pharmaceutical and biochemical semi-finished products, especially for use in medicines
    4. Development, examination and testing of medicines, development of testsystems for the products mentioned in class 5
    5. Licenses.